Dexmedetomidine: A review of clinical applications

Current Opinion in Anaesthesiology

Volumn 21, Issue 4, 2008, Pages 457-461

  Carollo, Dominic S ^a   Nossaman, Bobby D ^a   Ramadhyani, Usha ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Awake craniotomy; Bariatric surgery; Cardiac surgery; Dexmedetomidine; ICU sedation; Pediatric sedation

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; BENZODIAZEPINE; DEXMEDETOMIDINE; FENTANYL; LORAZEPAM; MIDAZOLAM; MORPHINE; OPIATE; PLACEBO; PROPOFOL; SEVOFLURANE;

ADD ON THERAPY; ADULT; AGITATION; ANESTHESIA; ARTIFICIAL VENTILATION; BARIATRIC SURGERY; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC PROCEDURE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; HEART PROTECTION; HEART SURGERY; HOSPITALIZED CHILD; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; INTUBATION; LENGTH OF STAY; LOW DRUG DOSE; NEUROPROTECTION; NEUROSURGERY; PAIN; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; SINUS BRADYCARDIA; SURGICAL PATIENT; TACHYPHYLAXIS; TOPICAL ANESTHESIA; XEROSTOMIA;

ADULT; ANIMALS; BARIATRIC SURGERY; CHILD; DEXMEDETOMIDINE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS;

EID: 59149095717     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328305e3ef     Document Type: Review

References (49)

1. Kauppila T, Kemppainen P, Tanila H, et al. Effect of systemic medetomidine, an alpha2 adrenoreceptor agonist, on experimental pain in humans. Anesthe-siology 1991; 74:3-8.
2. Venn R, Bradshaw C, Spencer R, et al. Preliminary experience of dexmede-tomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999; 54:1136-1142.
3. 2 adrenergic agonists. Anesthesiology 2000; 93:1345-1349.
4. Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists: their pharmacology and therapeutic role. Anaesthesia 1999; 54:146-165.
5. Nelson LE, You T, Maze M, Franks NP. Evidence that the mechanism of hypnotic action in dexmedetomidine and muscimol-induced anesthesia converges on the endogenous sleep pathway. Anesthesiology 2001; 95:A1368.
6. 2-adrenergic agonist: a review of its pharmacodynamic characteristics. Drugs Future 1993; 18:49-56.
7. Frangoulidou E, Kuhlen R, Marenghi C. Sedative agents and respiratory depression: a unique profile of dexmedetomidine. In: Maze M, Morrison P, editors. Redefining sedation. London, UK: The Royal Society of Medicine Press Ltd.; 1998. pp. 40-50.
8. Precedex™ (dexmedetomidine) [package insert]. North Chicago, Illinois: Abbott Laboratories.
9. Hassan E. Dexmedetomidine: a viewpoint by Dr Erkan Hassan. Drugs 2000; 59:269-270.
10. Shehabi Y, Ruettimann U, Adamson H, et al. Dexmedetomidine infusion for more than 24 h in critically ill patients: sedative and cardiovascular effects. Intensive Care Med 2004; 30:2188-2196.
11. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guideline for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30:119-141.
12. Mantz J, Singer M. Importance of patient orientation and rousability as components of intensive care unit sedation. In: Maze M, Morrison P, editors. Redefining sedation. London, UK: The Royal Society of Medicine Press Ltd.; 1998. pp. 23-29.
13. Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass surgery; dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothor Vasc Anesth 2003; 17:576-584.
14. Venn RM, Grounds RM. Comparison between dexmedetomidine and propo-fol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 2001; 87:684-690.
15. ElbaradieS, El Mahalawy FH,Solyman AH. Dexmedetomidine versus propofol for short-term sedation of postoperative mechanically ventilated patients. J Egypt Nat Cancer Inst 2004; 16:153-158.
16. Corbett SM, Rebuck JA, Greene CM, et al. Dexmedetomidine does not improve patient satisfaction when compared to propofol during mechanical ventilation. Crit Care Med 2005; 33:940-945.
17. Gerlach AT, Dasta J. Dexmedetomidine: an updated review. Ann Pharma-cother 2007; 41:245-252.
18. Lerch C, Park GR. Sedation and analgesia. BMJ 1999; 55:76-95.
19. Pandharipande PP, Pun BT, Her DL, Maze M, et al. Effect of sedation with dexmedetomidine versus lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298:2644-2653.
20. Dasta JF, Kane-Gill SL, Durtschi AJ. Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data. Ann Pharmacother 2004; 38:1130-1135.
21. Tobias JD, BerkenboschJW. Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 2004; 97: 451 -455.
22. Sturaitis MK, Kroin JS, Swamidoss CP, et al. Effects of intraoperative dexmedetomidine infusion on hemodynamic stability during brain tumor resection [abstract]. Anesthesiology 2002; 97:A310.
23. Tanskanen PE, Kyttä JV, Randell TT, Aantaa RE. Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery: a double-blind, randomized and placebo-controlled study. Br J Anaesth 2006; 97:65s8-665.
24. Frost E, Booij L. Anesthesia in the patient for awake craniotomy. Curr Opin Anaesthesiol 2007; 20:331-335.
25. Mack PF, Perrine K, Kobylarz E, et al. Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol 2004; 16:20-25.
26. Bekker A, Sturaitis MK. Dexmedetomidine for neurological surgery. Neurosurgery 2005; 57:1 -10.
27. Mack PF, Perrine K, Kobylarz E, et al. Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol 2004; 16:20-25.
28. Korogulu A, Demirbilek S, Teksan H, et al. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth 2005; 94:821 -824.
29. Korogulu A, Teksan H, Sagir O, et al. A comparison of the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging. Anesth Analg 2006; 103:63-67.
30. Shukry M, Ramadhyani U. Dexmedetomidine as the primary sedative agent for brain radiation therapy in a 21-month old child. Paediatr Anaesth 2005; 15: 241 -242.
31. Shukry M, Ramadhyani U. Does dexmedetomidine prevent emergence delirium in children after sevoflurane-based general anesthesia? Paediatr Anaesth 2005; 15:1098-1104.
32. Shukry M, Guruli Z, Ramadhyani U. Suspected malignant hyperthermia in a child with laminin alpha2 (merosin) deficiency in the absence of a triggering agent. Paediatr Anaesth 2006; 16:462-465.
33. Ard J, Doyle W, Bekker A. Awake craniotomy with dexmedetomidine in pediatric patients. J Neurosurg Anesthesiol 2003; 15:263-266.
34. Antilla M, Penttila J, Vuorilehto L, Scheinin H. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharm 2003; 56: 691 -693.
35. Yuen V, Irwin M, Hui T, et al. A double-blind crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine. Anesth Analg 2007; 105:374-380.
36. Talon M, Woodson L, Sherwood E, et al. Nasal dexmedetomidine is comparable to midazolam as a perioperative sedation for children [ASA presentation]. Anesthesiology 2007; 107:A1398.
37. Cooper L, Samson R, Gallagher C, et al. Dexmedetomidine provides excellent sedation for elective, awake fiberoptic intubation. Anesthesiology 2005; 103:A1449.
38. Ruesch S, Levy J. Treatment of persistent tachycardia with dexmedetomidine during off-pump cardiac surgery. Anesth Analg 2002; 95:316-318.
39. Ickeringill M, Shehabi Y, Adamson H, Ruettimann U. Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation: haemodynamic effects and efficacy. Anaesth Intensive Care 2004; 32:741 -745.
40. WijeysunderaDN,NaikJS, Beattie WS.Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 2003; 114:742-752.
41. Jalonen J, Hynynen M, Kuitunen A, et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology 1997; 86:331 -345.
42. But AK, Ozgul U, Erdil F, et al. The effects of preoperative dexmedetomidine infusion on hemodynamics in patients with pulmonary hypertension undergoing mitral valve replacement surgery. Acta Anaesthesiol Scand 2006; 50:1207-1212.
43. McCarty TM, Arnold DT, Lamont JP, et al. Optimizing outcomes in bariatric surgery: outpatient laparoscopic gastric bypass. Ann Surg 2005; 242:494-498; discussion 498-450.
44. Ramsay MA. Tracheal resection in the morbidly obese patient: the role of dexmedetomidine. J Clin Anesth 2006; 18:452.
45. Feld JM, Hoffman WE, Stechert MM, et al. Fentanyl or dexmedetomidine combined with desfluranefor bariatric surgery. J Clin Anesth 2006; 18:24-28.
46. Hofer RE, Sprung J, et al. Anesthesia for a patient with morbid obesity using dexmedetomidine without narcotics. Can J Anaesth 2005; 52:176-180.
47. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. Anesthesiology 1992; 77:1134-1142.
48. Kallio A, Scheinin M, Koulu M, et al. Effects of dexmedetomidine, a selective alpha2-adrenorecptor agonist on hemodynamic control mechanisms. Clin Pharmacol Ther 1989; 46:33-42.
49. Pandharipane P, Ely EW, Maze M. Dexmedetomidine for sedation and perioperative management of critically ill patients. Semin Anesth Periop Med Pain 2006; 25:43-50.